QQQ   423.81 (-0.48%)
AAPL   167.04 (-0.57%)
MSFT   405.17 (-1.62%)
META   501.43 (+1.47%)
GOOGL   156.47 (+0.64%)
AMZN   179.38 (-1.05%)
TSLA   150.88 (-2.94%)
NVDA   846.00 (+0.67%)
AMD   154.54 (+0.34%)
NIO   4.02 (+2.81%)
BABA   68.91 (+0.13%)
T   16.25 (+0.81%)
F   12.02 (-0.17%)
MU   112.45 (-3.34%)
GE   153.79 (-1.21%)
CGC   8.06 (+24.19%)
DIS   112.85 (-0.08%)
AMC   2.93 (-1.68%)
PFE   25.33 (-0.35%)
PYPL   62.19 (-1.69%)
XOM   118.49 (-0.12%)
QQQ   423.81 (-0.48%)
AAPL   167.04 (-0.57%)
MSFT   405.17 (-1.62%)
META   501.43 (+1.47%)
GOOGL   156.47 (+0.64%)
AMZN   179.38 (-1.05%)
TSLA   150.88 (-2.94%)
NVDA   846.00 (+0.67%)
AMD   154.54 (+0.34%)
NIO   4.02 (+2.81%)
BABA   68.91 (+0.13%)
T   16.25 (+0.81%)
F   12.02 (-0.17%)
MU   112.45 (-3.34%)
GE   153.79 (-1.21%)
CGC   8.06 (+24.19%)
DIS   112.85 (-0.08%)
AMC   2.93 (-1.68%)
PFE   25.33 (-0.35%)
PYPL   62.19 (-1.69%)
XOM   118.49 (-0.12%)
QQQ   423.81 (-0.48%)
AAPL   167.04 (-0.57%)
MSFT   405.17 (-1.62%)
META   501.43 (+1.47%)
GOOGL   156.47 (+0.64%)
AMZN   179.38 (-1.05%)
TSLA   150.88 (-2.94%)
NVDA   846.00 (+0.67%)
AMD   154.54 (+0.34%)
NIO   4.02 (+2.81%)
BABA   68.91 (+0.13%)
T   16.25 (+0.81%)
F   12.02 (-0.17%)
MU   112.45 (-3.34%)
GE   153.79 (-1.21%)
CGC   8.06 (+24.19%)
DIS   112.85 (-0.08%)
AMC   2.93 (-1.68%)
PFE   25.33 (-0.35%)
PYPL   62.19 (-1.69%)
XOM   118.49 (-0.12%)
QQQ   423.81 (-0.48%)
AAPL   167.04 (-0.57%)
MSFT   405.17 (-1.62%)
META   501.43 (+1.47%)
GOOGL   156.47 (+0.64%)
AMZN   179.38 (-1.05%)
TSLA   150.88 (-2.94%)
NVDA   846.00 (+0.67%)
AMD   154.54 (+0.34%)
NIO   4.02 (+2.81%)
BABA   68.91 (+0.13%)
T   16.25 (+0.81%)
F   12.02 (-0.17%)
MU   112.45 (-3.34%)
GE   153.79 (-1.21%)
CGC   8.06 (+24.19%)
DIS   112.85 (-0.08%)
AMC   2.93 (-1.68%)
PFE   25.33 (-0.35%)
PYPL   62.19 (-1.69%)
XOM   118.49 (-0.12%)
NASDAQ:CME

CME Group (CME) Stock Price, News & Analysis

$209.60
+1.18 (+0.57%)
(As of 03:21 PM ET)
Today's Range
$207.77
$210.36
50-Day Range
$204.00
$221.35
52-Week Range
$175.73
$223.80
Volume
655,641 shs
Average Volume
1.76 million shs
Market Capitalization
$75.45 billion
P/E Ratio
23.63
Dividend Yield
2.19%
Price Target
$215.70

CME Group MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
3.7% Upside
$215.70 Price Target
Short Interest
Healthy
1.23% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-0.26
Upright™ Environmental Score
News Sentiment
0.81mentions of CME Group in the last 14 days
Based on 21 Articles This Week
Insider Trading
Acquiring Shares
$14,520 Bought Last Quarter
Proj. Earnings Growth
1.05%
From $9.56 to $9.66 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.55 out of 5 stars

Finance Sector

162nd out of 834 stocks

Security & Commodity Brokers, Dealers, Exchanges & Services Industry

3rd out of 9 stocks

CME stock logo

About CME Group Stock (NASDAQ:CME)

CME Group Inc., together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services. The company also provides clearing house services, including clearing, settling, and guaranteeing futures and options contracts, and cleared swaps products traded through its exchanges; and trade processing and risk mitigation services. In addition, the company offers a range of market data services, including real-time and historical data services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. The company was founded in 1898 and is headquartered in Chicago, Illinois.

CME Stock Price History

CME Stock News Headlines

Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip? (CME)
Lululemon's dip is potentially the best deal in the apparel industry today, analysts and institutions still see double-digit upside for the stock
Kinder Morgan Stock Bid Up In An Oil Breakout (CME)
Kinder Morgan is the oil stock that stood out to markets enough to bring its valuation to a premium above peers, and analysts still see a double-digit upside
[Urgent!] Generational Wealth Gameplan
A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.
Citi’s Results Say This About The Stock Market
Investors now have an inside look at what one of Wall Street's biggest names is doing with its money. Corporations and clients all see new highs in stocks
Blackstone’s $10 Billion Bet on Property Prices Going Up (CME)
Residential property prices could be on the rise soon, as Blackstone just made a $10 billion bet into the sector, and one other REIT could be next in line
Taylor Morrison: A Home Building Stock You Can Buy at a Discount (CME)
Taylor Morrison stock is one homebuilder stock that still has some upside left to it, analysts like the way fundamentals have developed.
Institutions Think This Consumer Stock Could Break Higher
Markets are preparing for the coming interest rate cycle proposed by the Federal Reserve (the Fed). Though most sectors have priced in this potential pivot, some have yet to reflect this trend higher.
Institutions Think This Consumer Stock Could Break Higher (CME)
PriceSmart is the stock where investment giants found the right opportunity to get above-average growth at the least risk possible. A cycle-beating business
[Urgent!] Generational Wealth Gameplan
A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.
3 Consumer Staples Stocks Setting up for a Breakout
The swing is coming in this next market cycle. While markets may have priced in potential interest rate cuts from the Federal Reserve (the Fed), some stocks have yet to reach their full potential.
3 Consumer Staples Stocks Setting up for a Breakout (CME)
Three consumer staples stocks could be set to benefit from current market uncertainty, until the Fed decides on the timing - and magnitude - of potential cuts
3 Stocks About to Book Gains on Building Products Demand
Investors often follow the latest trends in the U.S. economy and attempt to align their portfolios with the best industries, some of which could have a breakout in the coming months. The construction industry is one example, as the ISM Manufacturing PMI index and its cousin, the ISM Services PMI index, indicate a new expansionary trend in the space.
CME Group Inc. (NASDAQ:CME) Short Interest Up 18.2% in March
CME Group (NASDAQ:CME) Price Target Raised to $226.00
CME Group Inc. Class A
Analyst Scoreboard: 4 Ratings For CME Gr
See More Headlines
Receive CME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CME Group and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/14/2024
Ex-Dividend for 3/26 Dividend
3/07/2024
Dividend Payable
3/26/2024
Today
4/18/2024
Next Earnings (Confirmed)
4/24/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Finance
Industry
Security & commodity brokers, dealers, exchanges & services
Sub-Industry
Specialized Finance
Current Symbol
NASDAQ:CME
CUSIP
12572Q10
Employees
3,565
Year Founded
1848

Price Target and Rating

Average Stock Price Target
$215.70
High Stock Price Target
$245.00
Low Stock Price Target
$180.00
Potential Upside/Downside
+3.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
10 Analysts

Profitability

Net Income
$3.23 billion
Pretax Margin
74.45%

Debt

Sales & Book Value

Annual Sales
$5.58 billion
Cash Flow
$10.60 per share
Book Value
$74.43 per share

Miscellaneous

Free Float
358,915,000
Market Cap
$75.37 billion
Optionable
Optionable
Beta
0.49

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for April 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.

Get This Free Report

Should I Buy CME Group Stock? CME Pros and Cons Explained

Pros

Here are some ways that investors could benefit from investing in CME Group Inc.:

  • CME Group Inc. has a strong market presence and offers a diverse range of futures and options products based on various financial instruments, providing investors with ample opportunities for portfolio diversification.
  • The company provides clearing house services, ensuring the clearing, settling, and guaranteeing of futures and options contracts, which adds a layer of security for investors participating in these markets.
  • With a market cap of $75.99 billion, CME Group Inc. is a well-established player in the financial data and stock exchanges industry, offering stability and potential growth for investors.
  • CME Group Inc.'s stock performance has shown resilience, with a 12-month high of $223.80, indicating potential for capital appreciation for investors.
  • The company's consistent quarterly earnings results, such as the reported $2.37 earnings per share in the latest financial report, demonstrate financial strength and reliability, which can be attractive to investors seeking consistent returns.

Cons

Investors should be bearish about investing in CME Group Inc. for these reasons:

  • While CME Group Inc. has a strong market presence, the financial services industry is highly competitive and subject to regulatory changes, which could impact the company's operations and profitability.
  • As with any investment in financial markets, there are inherent risks associated with trading futures and options contracts, which could lead to potential losses for investors if market conditions are unfavorable.
  • The company's price-to-earnings-growth ratio of 4.79 may indicate that the stock is relatively expensive compared to its growth prospects, potentially limiting short-term gains for investors.
  • Investors should consider the company's beta of 0.49, indicating lower volatility compared to the market, which may result in slower price movements and potentially lower returns for more risk-seeking investors.
  • While CME Group Inc. offers a range of market data services, changes in technology and data analytics could pose challenges for the company in maintaining its competitive edge in the evolving financial services landscape.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, April 11, 2024. Please send any questions or comments about these CME Group pros and cons to contact@marketbeat.com.

CME Stock Analysis - Frequently Asked Questions

Should I buy or sell CME Group stock right now?

10 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last twelve months. There are currently 2 sell ratings, 6 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" CME shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CME, but not buy additional shares or sell existing shares.
View CME analyst ratings
or view top-rated stocks.

What is CME Group's stock price target for 2024?

10 brokers have issued 1-year price objectives for CME Group's stock. Their CME share price targets range from $180.00 to $245.00. On average, they predict the company's stock price to reach $215.70 in the next twelve months. This suggests a possible upside of 3.7% from the stock's current price.
View analysts price targets for CME
or view top-rated stocks among Wall Street analysts.

How have CME shares performed in 2024?

CME Group's stock was trading at $210.60 at the beginning of the year. Since then, CME shares have decreased by 1.3% and is now trading at $207.92.
View the best growth stocks for 2024 here
.

Are investors shorting CME Group?

CME Group saw a increase in short interest in the month of March. As of March 31st, there was short interest totaling 4,420,000 shares, an increase of 18.2% from the March 15th total of 3,740,000 shares. Based on an average daily trading volume, of 1,750,000 shares, the short-interest ratio is presently 2.5 days. Currently, 1.2% of the shares of the company are sold short.
View CME Group's Short Interest
.

When is CME Group's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, April 24th 2024.
View our CME earnings forecast
.

How can I listen to CME Group's earnings call?

CME Group will be holding an earnings conference call on Wednesday, April 24th at 8:30 AM Eastern. Interested parties can register for or listen to the call using this link.

How were CME Group's earnings last quarter?

CME Group Inc. (NASDAQ:CME) posted its quarterly earnings data on Wednesday, February, 14th. The financial services provider reported $2.37 EPS for the quarter, beating the consensus estimate of $2.27 by $0.10. The financial services provider earned $1.44 billion during the quarter, compared to the consensus estimate of $1.43 billion. CME Group had a net margin of 57.83% and a trailing twelve-month return on equity of 12.32%. The business's revenue was up 19.2% on a year-over-year basis. During the same period in the previous year, the company earned $1.92 EPS.
Read the conference call transcript
.

How often does CME Group pay dividends? What is the dividend yield for CME Group?

CME Group announced a quarterly dividend on Thursday, February 8th. Shareholders of record on Friday, March 8th will be paid a dividend of $1.15 per share on Tuesday, March 26th. This represents a $4.60 annualized dividend and a dividend yield of 2.21%. The ex-dividend date is Thursday, March 7th. This is an increase from the stock's previous quarterly dividend of $1.10.
Read our dividend analysis for CME
.

Is CME Group a good dividend stock?

CME Group (NASDAQ:CME) pays an annual dividend of $4.60 per share and currently has a dividend yield of 2.23%. The company has been increasing its dividend for 14 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 51.86%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CME will have a dividend payout ratio of 47.62% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CME.

What is Terry Duffy's approval rating as CME Group's CEO?

294 employees have rated CME Group Chief Executive Officer Terry Duffy on Glassdoor.com. Terry Duffy has an approval rating of 83% among the company's employees. 80.0% of employees surveyed would recommend working at CME Group to a friend.

What other stocks do shareholders of CME Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CME Group investors own include NVIDIA (NVDA), Mastercard (MA), PayPal (PYPL), Walt Disney (DIS), Visa (V), Netflix (NFLX), Boeing (BA), Alibaba Group (BABA), Cisco Systems (CSCO) and Intel (INTC).

Who are CME Group's major shareholders?

CME Group's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Sarasin & Partners LLP (0.63%), Guinness Asset Management LTD (0.24%), Congress Asset Management Co. MA (0.11%), Los Angeles Capital Management LLC (0.07%), Franklin Street Advisors Inc. NC (0.05%) and Global Assets Advisory LLC (0.04%). Insiders that own company stock include Bryan T Durkin, Charles P Carey, Daniel R Glickman, Dennis Suskind, Derek Sammann, Elizabeth A Cook, Hilda Harris Piell, Howard J Siegel, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Ken Vroman, Kevin Kometer, Martin J Gepsman, Martin J Gepsman, Sean Tully, Sunil Cutinho, Terrence A Duffy, Timothy Francis Mccourt, Timothy S Bitsberger and William R Shepard.
View institutional ownership trends
.

How do I buy shares of CME Group?

Shares of CME stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CME) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners